2018
DOI: 10.1016/j.reprotox.2017.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Peroxisome proliferator activated receptor gamma in human placenta may mediate the adverse effects of phthalates exposure in pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(5 citation statements)
references
References 35 publications
0
5
0
Order By: Relevance
“…First, phthalate diesters in this study were measured in cord blood, but the recommended approach for assessing phthalate exposure is to measure their metabolites in urine because (i) the diesters have been shown to be non-persistent in humans; they are oxidized quickly and the monoesters are excreted in urine, and (ii) parent phthalate compound contamination is difficult to avoid in the laboratory setting, and may overshadow any parent compounds in blood [ 110 ]. A similar limitation was also present in a recent study of 207 women from Southwest China, reporting associations of higher cord blood concentrations of DiBP, DBP, and DEHP with higher placental (sampled near the cord) PPARG protein at delivery, higher DEHP with higher cord blood estradiol, and higher DBP and DEHP with lower cord blood estriol [ 111 ]. More importantly for assessing sex-specific outcomes, unlike the studies by LaRocca et al , modification by fetal sex (interaction between exposure and fetal sex) was not assessed prior to testing associations stratified by sex.…”
Section: Sex-specific Placental Outcomesmentioning
confidence: 75%
“…First, phthalate diesters in this study were measured in cord blood, but the recommended approach for assessing phthalate exposure is to measure their metabolites in urine because (i) the diesters have been shown to be non-persistent in humans; they are oxidized quickly and the monoesters are excreted in urine, and (ii) parent phthalate compound contamination is difficult to avoid in the laboratory setting, and may overshadow any parent compounds in blood [ 110 ]. A similar limitation was also present in a recent study of 207 women from Southwest China, reporting associations of higher cord blood concentrations of DiBP, DBP, and DEHP with higher placental (sampled near the cord) PPARG protein at delivery, higher DEHP with higher cord blood estradiol, and higher DBP and DEHP with lower cord blood estriol [ 111 ]. More importantly for assessing sex-specific outcomes, unlike the studies by LaRocca et al , modification by fetal sex (interaction between exposure and fetal sex) was not assessed prior to testing associations stratified by sex.…”
Section: Sex-specific Placental Outcomesmentioning
confidence: 75%
“…One of the proposed modes of action of DEHP during pregnancy that contributes to adverse health effects is through activation of the peroxisome proliferator activated receptor (PPAR) gamma (γ) signaling pathway [64]. This is a potential pathway through which prenatal exposure to DEHP may affect children's immune system development.…”
Section: Discussionmentioning
confidence: 99%
“…However, some of these chemicals remain in the body without metabolizing and accumulate over time; phthalates can diffuse into the lipid bilayer of cells and spread to neighboring tissues because of their lipophilic structure (23). In-utero, chronic, or acute exposure results in impaired oxidative stress metabolism in the liver associated with the impaired endocrine system, cardiovascular diseases, obesity, infertility, and diabetes, according to the literature (11)(12)(13). Thus, we investigated the impact of in-utero exposure to the DHP and DCHP on the oxidative stress-induced histopathological changes in the liver as the critical metabolic organ for energy and detoxification metabolisms first time in the literature (22).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, in-utero exposure to phthalates has adverse health effects in adulthood, including diabetes, metabolic disorders, obesity, cancer, and cardiovascular diseases. On the other hand, there is no information about the biochemical and histopathologic effects of prenatal phthalate exposure in adulthood associated with liver metabolism (11).…”
Section: Introductionmentioning
confidence: 99%